ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

BELL Belluscura Plc

10.00
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Belluscura Plc LSE:BELL London Ordinary Share GB00BD3B8Z11 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.00 9.00 11.00 10.00 10.00 10.00 65,000 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 825k -18.52M -0.1100 -0.91 16.84M
Belluscura Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker BELL. The last closing price for Belluscura was 10p. Over the last year, Belluscura shares have traded in a share price range of 7.25p to 26.00p.

Belluscura currently has 168,408,232 shares in issue. The market capitalisation of Belluscura is £16.84 million. Belluscura has a price to earnings ratio (PE ratio) of -0.91.

Belluscura Share Discussion Threads

Showing 351 to 374 of 825 messages
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older
DateSubjectAuthorDiscuss
16/3/2022
11:28
Good morning
Decent share price gain for BELL so far today though maybe simply because BELL share price recent fall was overdone.

maytrees
15/3/2022
11:21
Greetings Buywell4
Charts probably less important than Russian War developments.
BELL's O2 etc are reported thus:

"We are delighted with the progress we made in 2021, having successfully launched our first X-PLOR product into the growing supplemental oxygen market. Alongside this, we have continued to develop our follow-on products which will be launched in 2022. The Company has a strong balance sheet and is well positioned to deliver substantial growth in 2022. We look forward to the future with confidence."

Charts not for me on this one but of course DYOR

maytrees
15/3/2022
11:08
Chart is now going only one way, and unfortunately it’s not up. Broken though a key support, next stop 60p. Would like to more positive but charts don’t lie.
buywell4
08/3/2022
23:10
POST REMOVED
buywell2
06/3/2022
20:57
---- The future of Digital Health in the UK is by the adoption of 'Virtual Wards' -----

Definition of technology-enabled virtual wards

Virtual wards should be technology-enabled to maximise the opportunity they offer for both patients, carers and staff. Technology-enablement means the management of patients via a digital platform. In a technology-enabled model, patients measure agreed vital signs and enter data into an app or website. In some cases, they wear a device that continuously monitors and reports vital signs.

Clinical teams see individual patient measurements for the cohort of patients they are responsible for via a dashboard. The platforms or technology software ensures they are alerted when any patient moves outside agreed parameters, allowing them to take appropriate action. Patients should be considered for a technology-enabled service where one exists, however it is important that alternatives are available to avoid digital exclusion and take account of personal choice. It is also important consideration is given to other opportunities technology may offer such as the use of point of care testing or remote diagnostics to support virtual wards.




Devices like oxygen concentrators are regularly used by people in such 'virtual ward' settings ie at their home or in a care home , as part of their oxygen therapy ---

Such devices that can operate with an APP which monitors their vital signs 24/7 even whilst they are asleep --- and updates the NHS local 'dashboard' on a real time basis so as to immeadiatly flag up a change in vital signs which would be indicative of interventaion/changes being made ie an emergency or alteration to the oxygen rate supplied for example

Any such INTELLIGENT type of oxygen concentrator that utilizes an APP that can do this automatically without the patient having to keep taking manual readings and inputting them themselves for a local NHS clinical team to then inspect --- would imo by welcomed by the NHS as it would integrate very well in the virtual ward adoption roll out now underway.

One would imagine that the USA might also be looking at how this NHS virtual ward initiative progresses with a view to doing the same thing



Monitoring

Level of monitoring required, for example continuous monitoring via wearables or spot checks where patients use connected devices to record vital signs at agreed time or enter data from disconnected devices, or a combination of both

Accessibility

Software should meet the accessibility and usability standards set out in DTACs. It is important to consider the range of communication options to include web, apps, video consultation, voice calls and texts to ensure it is appropriate for the broadest range of patients.

buywell3
22/2/2022
10:22
Prospective profit seems to be what markets look for these days.
On that I am optimistic but dyor.

maytrees
22/2/2022
10:08
£90m enterprise value for a company that has approx annualised sales of £1m and makes a substantial loss?

Going to have to get a lot of things right.

dr biotech
22/2/2022
09:54
Hi maytrees.....indeed results weren't really expected to show much and like you say, share price reaction more likely result of wider market malaise.

Getting back to a point where I might look to buy back in....though I'm not inclined to rush given current uncertainties.

tanners
22/2/2022
08:40
Good morning
Results out and share price substantially down though probably more to do with the Russian manoeuvres than with anything else.
I added a few at sub 94p but dyor.

maytrees
22/2/2022
07:44
Find out here directly from Belluscura CEO Bob Rauker, how the business' is set up to deliver on its exciting long term growth potential.

www.linkedin.com/posts/paul-hill-a5994116_qa-with-belluscura-ceo-robert-rauker-vox-activity-6901792310779355136-4vda

Alongside the latest valuation & investor commentary

www.linkedin.com/posts/paul-hill-a5994116_bell-bell-bell-activity-6901787341560893440-tbn3

brummy_git
21/2/2022
09:42
Good morning

Small price drop just before prelims is odd though the BELL did say "mid February" for the results which has just passed.

My guess is that with the USA on holiday today, the results will be tomorrow or Wednesday this week.

maytrees
19/2/2022
23:23
==== Could the Belluscura current portable device be used as a CPAP ? ====

There would seem to be a requirement for various levels of supplementary oxygen levels regarding the treatment of Sleep Apnea and OSA



Whilst the current Zeolite modules strip out the nitrogen in order to produce 95% oxygen --- those modules could be made to strip out circa 50% of the nitrogen or only 5% of the nitrogen for example in order to provide CPAP therapy for Sleep Apnea sufferers

IF

They could provide continuous flow ( which the new ones due to be released soon will )

AND

If they can provide the presures needed to treat Sleep Apnea sufferers so as to keep their airways open when asleep as nighttime

This should be easy to do imo

Thus the present IP should be ok to use and minor design changes would imo only be needed eg zeolite and pressure change ( possible two settings )

A whole new MASSIVE market then opens up to what is in effect the same IP protected device

With a device that can offer additional ' partial oxygen therapy ' if and when required by means of a zeolite module change .

Don't think ANYONE offers this --- please tell me if you find one

buywell2
17/2/2022
03:56
Governments need to wake up to TWO of the main causes of spiraling health costs

Namely Obesity and OSA ---- BOTH are interrelated

Obstructive Sleep Apnea and Obesity: Implications for Public Health



Conclusion


This review highlights the impact of obesity on OSA is evident.

Indeed, in several populations across different cultures, the positive relationship between obesity and OSA was pronounced. This represents an important public health crisis that demands multi-layered interventions.

To cope with this increasing and seriously preventable health issue, we emphasize the need to minimize the consumption of junk and fast food, increase the consumption of fresh fruits and vegetables. Other important habits are drinking water instead of juice, soda or alcohol; as well as smoking cessation.

In addition to making dietary changes engaging in physical exercise is necessary. If medical and/or lifestyle medication therapies fail, then surgical interventions are another option to treat obesity and its associated comorbidities.

Surgical procedures which can drastically reduce obesity and its related comorbidities ultimately improving mortality rates.


To improve public health, obesity and its associated comorbidities should be seriously considered. Solving this issue is not only the responsibility of an individual and a healthcare worker, but it should be properly addressed by government officials to improve the health of individuals and make an overall healthier society.

here here
buywell AD 2022




Meantime the vicious circle continues

buywell3
17/2/2022
03:45
Due to the lack of Government actions and initiatives in many countries because of lobbying by the incumbent food industries

Never has the need for oxygen therapy or CPAP therapy been as great as it now is

The world population is by and large very very unhealthy and the prognosis is that things are getting worse due to the Covid-19 pandemic and obesity rates

buywell3
16/2/2022
10:25
Good morning
Added a few more today.
Prelims expected imminently and are expected to be good imho.

maytrees
15/2/2022
21:54
In the USA it looks like CPAP therapy is payed for by Medicare



Could the modification of the present design to access this huge market be as simple as NOT including the modules that strip out the nitrogen and other gases ?

And providing the air pressure/s best suited to CPAP therapy for OSA ?

Does not this FDA directive cover such mods ? and could therefore be fast tracked


Having a light portable CPAP for daytime use might be a need for some worst case OSA sufferers --- the Belluscura unit fits the bill imo

Seems to be a very common problem with over 60's Americans


Obstructive Sleep Apnea leads to many other chronic health conditions


44% of all Americans are now obese and rates are getting worse
OSA is directly attributable to obesity --- CPAP therapy is recognized as a treatment for OSA sufferers


-------------------------------------------------------------------------


Conclusion:

The use of CPAP machines is set to rise at circa 8% in America from now through till 2027

With obesity rates rising this could go higher

If the Belluscura designs can easily be modified to become CPAP devices then a win/win seems a logical outcome

Medicare funding underscores this

OSA is a ticking timebomb in the USA with around 80% of all over 60's not yet aware that they have or are developing OSA

buywell3
14/2/2022
21:54
Quite a big market opportunity then

Globally, more than 1 billion people suffer from sleep apnea which makes the disease a global challenge. Although sleep apnea is treatable, 80% of those suffering remain undiagnosed, while waiting lists can exceed eight months and the diagnosis is a lengthy and uncomfortable process.



Whilst an oxygen concentrator is NOT a CPAP --- the designers could imo consider making the changes necessary in order to make it one thus addressing an additional and very lucrative growing market

buywell3
11/2/2022
15:57
Added a few

"The Group expects to release its preliminary results for the year to 31 December 2021 in mid-February."

maytrees
09/2/2022
13:25
Good afternoon
BELL prelims soon?

maytrees
04/2/2022
16:15
Justin & I talk about Belluscura (starts 39:15) here in today's Stock Picking video.

www.youtube.com/watch?v=pT7NlRWpmC0&t=2s

brummy_git
01/2/2022
21:02
buywell expects Belluscura to appoint new Distributors in several other countries in 2022 as they are currently in talks with interested parties now.

The new CX and DX continuous flow oxygen concentrators will also start to be sold soon


Other oxygen related developments including AI and hospital patient care are being discussed --- this will mean new areas of growth opening up imo

Belluscura has several patents pending in the above area

One of which has just received a 'Notice of Allowance' and is CPAP related so expect an RNS within the next week or so imo

dyor

buywell2
29/1/2022
16:21
Exciting year ahead for bellhttps://twitter.com/Belluscura/status/1487126574667284485?t=v4pUr9_zuYJJySv5TKuaYw&s=19
segaris
28/1/2022
13:11
Not sure how the previous email concerns BELL. Has the company expanded from oxygenators?
maytrees
28/1/2022
06:36
---------------- BA.2 a new omicron variant ---------------------

Previously referred to as the omicron 'stealth' variant ; this new variant is now spreading and is in 40 countries

Preliminary studies in Denmark where BA.2 is fast trying to become the dominant strain indicate it is around 50% more transmissible than the original omicron strain BA.1



It is also spreading in the UK and the USA and India



The issue is can people that have had omicron from BA.1 now catch BA.2 ?

Scientists are currently looking into this --- the outcome is very very important imo


BA.3 arrived in the USA just before Xmas


The implications being that whilst each omicron variant seems mild by comparison with Delta in terms of severity ---- if one can catch various new sub strains of it like BA.2 or BA.3 after acquiring BA.1 ---- then long COVID could still become a problem


dyor

buywell3
Chat Pages: Latest  21  20  19  18  17  16  15  14  13  12  11  10  Older

Your Recent History

Delayed Upgrade Clock